Myxoma Virus-Loaded Mesenchymal Stem Cells in Experimental Oncolytic Therapy of Murine Pulmonary Melanoma

Oncolytic viruses can target neoplasms, triggering oncolytic and immune effects. Their delivery to melanoma lesions remains challenging. Bone-marrow-derived mesenchymal stem cells (MSCs) were shown to be permissive for oncolytic myxoma virus (MYXV), allowing its transfer to melanoma cells, leading t...

Celý popis

Podrobná bibliografie

Hlavní autoři:	Joanna Jazowiecka-Rakus, Aleksander Sochanik, Aleksandra Rusin, Agata Hadryś, Wojciech Fidyk, Nancy Villa, Masmudur M. Rahman, Ewa Chmielik, Lina S. Franco, Grant McFadden
Médium:	Artigo
Jazyk:	Inglês
Vydáno:	Elsevier 2020-09-01
Edice:	Molecular Therapy: Oncolytics
Témata:	mesenchymal stem cells myxoma virus melanoma oncolytic virotherapy
On-line přístup:	http://www.sciencedirect.com/science/article/pii/S2372770520301078
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!